Hot Features
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) acro... Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.14 | -6.57276995305 | 2.13 | 2.4998 | 1.77 | 49321 | 2.02413332 | CS |
| 4 | -1 | -33.4448160535 | 2.99 | 3.2 | 1.71 | 50881 | 2.41147568 | CS |
| 12 | -1.86 | -48.3116883117 | 3.85 | 3.9566 | 1.71 | 26626 | 2.74879484 | CS |
| 26 | -4.05 | -67.0529801325 | 6.04 | 6.645 | 1.71 | 27825 | 3.86457836 | CS |
| 52 | -4.79 | -70.6489675516 | 6.78 | 9.5 | 1.71 | 192331 | 6.54362857 | CS |
| 156 | 0.88 | 79.2792792793 | 1.11 | 36 | 0.2914 | 505243 | 3.53376388 | CS |
| 260 | 0.54 | 37.2413793103 | 1.45 | 36 | 0.0846 | 1808192 | 0.87856033 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.